Welcome to Galleon, a leader in the pharmaceutical treatment of breathing-control disorders.
We apply sophisticated pharmacology, medicinal chemistry and drug-discovery tools to identify potential drug treatments for acute and chronic breathing-control conditions associated with surgical anesthesia, drug-induced respiratory depression, pain management and sleep apnea. Our product pipeline reflects recent advances in neurobiology, molecular biology and respiratory medicine which have enabled the development of a unique drug-discovery platform and promising drug candidates that are now undergoing clinical trials.
Galleon Video
Overview 
Corporate Fact Sheet
Galleon Pipeline
Click the chart to
view enlarged version
-
Well-Defined Markets: Galleon is focused on breathing control conditions, in particular respiratory depression in the acute care market and sleep apnea in the chronic care market.
Learn More -
Innovative Products: Galleon's product pipeline addresses the needs of both acute and chronic care patients. Our lead product has now completed a first in human study.
Learn More -
New Pathways: Galleon scientists have been using modern scientific tools to create a productive and cost-efficient drug discovery platform.
Learn More